415 related articles for article (PubMed ID: 30727754)
1. Osteopontin in Vascular Disease.
Lok ZSY; Lyle AN
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
Wolak T
Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
Scatena M; Liaw L; Giachelli CM
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
Cho HJ; Cho HJ; Kim HS
Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
[TBL] [Abstract][Full Text] [Related]
6. Role of osteopontin in cellular signaling and metastatic phenotype.
El-Tanani MK
Front Biosci; 2008 May; 13():4276-84. PubMed ID: 18508510
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin in Cardiovascular Diseases.
Shirakawa K; Sano M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356671
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin: a novel inflammatory mediator of cardiovascular disease.
Singh M; Ananthula S; Milhorn DM; Krishnaswamy G; Singh K
Front Biosci; 2007 Jan; 12():214-21. PubMed ID: 17127294
[TBL] [Abstract][Full Text] [Related]
9. Integrin β3 and CD44 levels determine the effects of the OPN-a splicing variant on lung cancer cell growth.
Sun SJ; Wu CC; Sheu GT; Chang HY; Chen MY; Lin YY; Chuang CY; Hsu SL; Chang JT
Oncotarget; 2016 Aug; 7(34):55572-55584. PubMed ID: 27487131
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
Uede T
Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin: role in immune regulation and stress responses.
Wang KX; Denhardt DT
Cytokine Growth Factor Rev; 2008; 19(5-6):333-45. PubMed ID: 18952487
[TBL] [Abstract][Full Text] [Related]
12. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.
Kazanecki CC; Uzwiak DJ; Denhardt DT
J Cell Biochem; 2007 Nov; 102(4):912-24. PubMed ID: 17910028
[TBL] [Abstract][Full Text] [Related]
13. Pre- and post-translational regulation of osteopontin in cancer.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Commun Signal; 2011 Jun; 5(2):111-22. PubMed ID: 21516514
[TBL] [Abstract][Full Text] [Related]
14. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis.
Shao JS; Sierra OL; Cohen R; Mecham RP; Kovacs A; Wang J; Distelhorst K; Behrmann A; Halstead LR; Towler DA
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1821-33. PubMed ID: 21597007
[TBL] [Abstract][Full Text] [Related]
15. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.
Courter D; Cao H; Kwok S; Kong C; Banh A; Kuo P; Bouley DM; Vice C; Brustugun OT; Denko NC; Koong AC; Giaccia A; Le QT
PLoS One; 2010 Mar; 5(3):e9633. PubMed ID: 20224789
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin.
Hui T; Sørensen ES; Rittling SR
Matrix Biol; 2015 Jan; 41():19-25. PubMed ID: 25446551
[TBL] [Abstract][Full Text] [Related]
17. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.
Anborgh PH; Mutrie JC; Tuck AB; Chambers AF
J Cell Mol Med; 2010 Aug; 14(8):2037-44. PubMed ID: 20597997
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
Ramaiah SK; Rittling S
Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
[TBL] [Abstract][Full Text] [Related]
20. The multiple functions and mechanisms of osteopontin.
Icer MA; Gezmen-Karadag M
Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
